Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Anders Bruun Mathiasen, Kristoffer Mads Aaris Henningsen, Marina Jurjevna Harutyunyan, Naja Dam Mygind & Jens Kastrup. (2010) YKL-40: A New Biomarker in Cardiovascular Disease?. Biomarkers in Medicine 4:4, pages 591-600.
Read now
Read now
M. Kazakova, T. Deneva, V. Uzunova & V. Sarafian. (2010) YKL-40 in Healthy Subjects. Biotechnology & Biotechnological Equipment 24:sup1, pages 125-128.
Read now
Read now
Julia S Johansen, Nicolai A Schultz & Benny V Jensen. (2009) Plasma YKL-40: A Potential New Cancer Biomarker?. Future Oncology 5:7, pages 1065-1082.
Read now
Read now
Frederick D. Coffman. (2008) Chitinase 3-Like-1 (CHI3L1): A Putative Disease Marker at the Interface of Proteomics and Glycomics. Critical Reviews in Clinical Laboratory Sciences 45:6, pages 531-562.
Read now
Read now
Julia S Johansen, Benny Vittrup Jensen, Anne Roslind & Paul A Price. (2007) Is YKL-40 a new therapeutic target in cancer?. Expert Opinion on Therapeutic Targets 11:2, pages 219-234.
Read now
Read now
Articles from other publishers (31)
Mónica Vázquez-Del Mercado, Felipe Pérez-Vázquez, Ana L. Márquez-Aguirre, Erika-Aurora Martínez-García, Efrain Chavarria-Avila, Carlos G. Ramos-Becerra, Andrea Aguilar-Vázquez, Marisol Godínez-Rubí, Beatriz-Teresita Martín-Márquez, Livier Gómez-Limón, Guillermo Márquez-De-La-Paz, Edy-David Rubio-Arellano & Oscar Pizano-Martinez. (2023) YKL-40 serum levels are predicted by inflammatory state, age and diagnosis of idiopathic inflammatory myopathies. Scientific Reports 13:1.
Crossref
Crossref
Sung Soo Ahn, Taejun Yoon, Yong-Beom Park, Maria Prendecki, Gurjeet Bhangal, Stephen P. McAdoo & Sang-Won Lee. (2021) Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study. Arthritis Research & Therapy 23:1.
Crossref
Crossref
Ting Zhao, Zhongping Su, Yingchang Li, Xiaoren Zhang & Qiang You. (2020) Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Chia-Chun Tseng, Yi-Jen Chen, Wei-An Chang, Wen-Chan Tsai, Tsan-Teng Ou, Cheng-Chin Wu, Wan-Yu Sung, Jeng-Hsien Yen & Po-Lin Kuo. (2020) Dual Role of Chondrocytes in Rheumatoid Arthritis: The Chicken and the Egg. International Journal of Molecular Sciences 21:3, pages 1071.
Crossref
Crossref
Young Ho Lee & Gwan Gyu Song. (2019) YKL-40 Levels in Rheumatoid Arthritis and Their Correlation with Disease Activity: A Meta-analysis. Journal of Rheumatic Diseases 26:4, pages 257.
Crossref
Crossref
Ming-Zhu Gao, Yun-Yu Wei, Qiang-Wei Xu, Rong Ji, Zhi-Jun Han & Ting-Wang Jiang. (2018) Elevated serum YKL-40 correlates with clinical characteristics in patients with polymyositis or dermatomyositis. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 56:1, pages 95-99.
Crossref
Crossref
Tuija Väänänen, Katriina Vuolteenaho, Hannu Kautiainen, Riina Nieminen, Timo Möttönen, Pekka Hannonen, Markku Korpela, Markku J. Kauppi, Kari Laiho, Oili Kaipiainen-Seppänen, Riitta Luosujärvi, Tea Uusitalo, Toini Uutela, Marjatta Leirisalo-Repo & Eeva Moilanen. (2017) Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial. PLOS ONE 12:8, pages e0183294.
Crossref
Crossref
Ryan E. Feaver, Banumathi K. Cole, Mark J. Lawson, Stephen A. Hoang, Svetlana Marukian, Brett R. Blackman, Robert A. Figler, Arun J. Sanyal, Brian R. Wamhoff & Ajit Dash. (2016) Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. JCI Insight 1:20.
Crossref
Crossref
Sunisa Thongsom, Wethaka Chaocharoen, Atit Silsirivanit, Sopit Wongkham, Banchob Sripa, Han Choe, Wipa Suginta & Chutima Talabnin. (2016) YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma. Tumor Biology 37:7, pages 9451-9463.
Crossref
Crossref
Yi-Xiang Jiang, Gui-Hong Zhang, Zhi-Min Wang & Hui Yang. (2014) Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage. Clinical Biochemistry 47:18, pages 302-306.
Crossref
Crossref
Gamze Kilic, Erkan Kilic, Ozgür Akgul & Salih Ozgocmen. (2014) Decreased Femoral Cartilage Thickness in Patients With Systemic Sclerosis. The American Journal of the Medical Sciences 347:5, pages 382-386.
Crossref
Crossref
Mehmet Tevfik Dorak & Yusuf Yazici. 2014. Understanding Evidence-Based Rheumatology. Understanding Evidence-Based Rheumatology
79
126
.
Dennis B Holmgaard, Lone H Mygind, Ingrid L Titlestad, Hanne Madsen, Svend Stenvang Pedersen, Julia S Johansen & Court Pedersen. (2013) Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease. BMC Pulmonary Medicine 13:1.
Crossref
Crossref
Signe Modvig, Matilda Degn, Henrik Horwitz, Stig P. Cramer, Henrik B. W. Larsson, Benedikte Wanscher, Finn Sellebjerg & Jette L. Frederiksen. (2013) Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis. PLoS ONE 8:10, pages e77163.
Crossref
Crossref
P. Jensen, C. Wiell, K. Milting, R.P. Poggenborg, M. Østergaard, J.S. Johansen & L. Skov. (2012) Plasma YKL‐40: a potential biomarker for psoriatic arthritis?. Journal of the European Academy of Dermatology and Venereology 27:7, pages 815-819.
Crossref
Crossref
Jon M. Einarsson, Sven Bahrke, Bjarni Thor Sigurdsson, Chuen-How Ng, Petur Henry Petersen, Olafur E. Sigurjonsson, Halldor JonssonJr.Jr., Johannes Gislason, Finnbogi R. Thormodsson & Martin G. Peter. (2013) Partially acetylated chitooligosaccharides bind to YKL-40 and stimulate growth of human osteoarthritic chondrocytes. Biochemical and Biophysical Research Communications 434:2, pages 298-304.
Crossref
Crossref
N. D. Mygind, K. Iversen, L. Køber, J. P. Goetze, H. Nielsen, S. Boesgaard, M. Bay, J. S. Johansen, O. W. Nielsen, V. Kirk & J. Kastrup. (2012)
The inflammatory biomarker
YKL
‐40 at admission is a strong predictor of overall mortality
. Journal of Internal Medicine 273:2, pages 205-216.
Crossref
Crossref
Jens Kastrup. (2012) Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?. Immunobiology 217:5, pages 483-491.
Crossref
Crossref
Benedikte Richter, Anne Roslind, Ulrik Hesse, Jørgen Nordling, Julia Sidenius Johansen, Thomas Horn & Alastair Bierre Hansen. (2010) YKL‐40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Histopathology 57:3, pages 371-383.
Crossref
Crossref
Dominika Wcislo-Dziadecka, Anna Kotulska, Ligia Brzezińska-Wcislo, Malgorzata Widuchowska, Anna Lis-Swiety, Magdalena Kopec-Medrek & Eugene J. Kucharz. (2010) Serum human cartilage glycoprotein-39 in patients with systemic sclerosis: relationship to skin and articular manifestation. Clinical Rheumatology 29:8, pages 933-935.
Crossref
Crossref
Nicolai A. Schultz & Julia S. Johansen. (2010) YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?. Cancers 2:3, pages 1453-1491.
Crossref
Crossref
SILJE W. SYVERSEN, GURO L. GOLL, DÉSIRÉE van der HEIJDE, ROBERT LANDEWÉ, PER IVAR GAARDER, SIGRID ØDEGÅRD, ESPEN A. HAAVARDSHOLM & TORE K. KVIEN. (2009) Cartilage and Bone Biomarkers in Rheumatoid Arthritis: Prediction of 10-year Radiographic Progression. The Journal of Rheumatology 36:2, pages 266-272.
Crossref
Crossref
Hyun-Joo Seol, Eun-Sung Lee, So-Eun Jung, Nan-Hee Jeong, Ji-Eun Lim, Sung-Hoon Park, Soon-Cheol Hong, Min-Jeong Oh & Hai-Joong Kim. (2009) Serum levels of YKL-40 and interleukin-18 and their relationship to disease severity in patients with preeclampsia. Journal of Reproductive Immunology 79:2, pages 183-187.
Crossref
Crossref
Tibet Kacira, Hakan Hanimoglu, Mine Kucur, Galip Zihni Sanus, Ali Metin Kafadar, Taner Tanriverdi & Mehmet Yasar Kaynar. (2008) Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage. Journal of Clinical Neuroscience 15:9, pages 1011-1016.
Crossref
Crossref
Anne K. Mylin, Niels Abildgaard, Julia S. Johansen, Niels F. Andersen, Lene Heickendorff, Therese Standal, Peter Gimsing & Lene M. Knudsen. (2007) High serum YKL‐40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients. European Journal of Haematology 80:4, pages 310-317.
Crossref
Crossref
Julia KzhyshkowskaAlexei GratchevSergij Goerdt. (2017) Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer. Biomarker Insights 2, pages 117727190700200.
Crossref
Crossref
M. Petersson, E. Bucht, B. Granberg & A. Stark. (2006) Effects of arginine-vasopressin and parathyroid hormone-related protein (1–34) on cell proliferation and production of YKL-40 in cultured chondrocytes from patients with rheumatoid arthritis and osteoarthritis. Osteoarthritis and Cartilage 14:7, pages 652-659.
Crossref
Crossref
STEVEN R. GOLDRING & MARY B. GOLDRING. 2006. Dynamics of Bone and Cartilage Metabolism. Dynamics of Bone and Cartilage Metabolism
843
869
.
DANIEL-HENRI MANICOURT, JEAN-PIERRE DEVOGELAER & EUGENE J.-M. A. THONAR. 2006. Dynamics of Bone and Cartilage Metabolism. Dynamics of Bone and Cartilage Metabolism
421
449
.
Masaaki Takahashi, Kenichi Naito, Masashi Abe, Tomokazu Sawada & Akira Nagano. (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 6:3.
Crossref
Crossref
Fabrizia Fusetti, Tjaard Pijning, Kor H. Kalk, Ebo Bos & Bauke W. Dijkstra. (2003) Crystal Structure and Carbohydrate-binding Properties of the Human Cartilage Glycoprotein-39. Journal of Biological Chemistry 278:39, pages 37753-37760.
Crossref
Crossref